Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
To development of clinical assessment technique using multi-radiotracer positron emission tomography/magnetic resonance (PET/MR) in prostate cancer
- to establish the optimal imaging technique of PET/MR using multiple radioactive tracers for prostate cancer
- to establish the imaging biomarker using PET/MR for clinical assessment of prostate cancer and early detection of recurrent prostate cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 2, 2013
CompletedFirst Posted
Study publicly available on registry
September 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedDecember 5, 2013
December 1, 2013
1.9 years
September 2, 2013
December 3, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
accuracy of PET/MR predicting localization and staging of prostate cancer
analysis of accuracy of PET/MR predicting localization and staging of prostate cancer by comparison of PET/MR findings with pathological mapping images after radical prostatectomy
1 week after radical prostatectomy
Secondary Outcomes (1)
accuracy of early detection and localization of recurrent prostate cancer
1 week after PET/MR imaging
Study Arms (1)
PET/MR
EXPERIMENTALMulti-radiotracer PET/MR will be performed to compare the accuracy of tumor detection in patient with primary prostate cancer
Interventions
Multi-radiotracer PET/MR will be performed in patients with primary and recurrent prostate cancer
Eligibility Criteria
You may qualify if:
- patient with prostate cancer before treatment
- patient with prostate cancer treated
- patient with prostate cancer recurrent
You may not qualify if:
- patient with contraindication for MRI
- Patient with severe renal impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeong Yeon Cho, MD
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2013
First Posted
September 10, 2013
Study Start
May 1, 2012
Primary Completion
April 1, 2014
Study Completion
December 1, 2014
Last Updated
December 5, 2013
Record last verified: 2013-12